The protocols in use come from extrapolation of animal data, pharmacokinetic studies, and clinical experience from practitioners who have incorporated the compound into their practice
Second, PPI treatment promotes the occurrence of CDAD, which is a common cause of IBD (Sokol et al., 2008)
Food Standards Agency data shows that more and more people are dramatically reducing their consumption of meat, with a rise in plant-based menus and offerings in the supermarkets
Third-party peptide testing through independent labs should confirm identity, purity (minimum 98% for neurological applications), and the absence of endotoxins, heavy metals, and residual solvents
Preclinical Research Dosing Models Animal model studies have explored GHK-Cu at the following ranges: Topical (in vitro/ex vivo): 10100 M concentrations in cell culture media Subcutaneous (rodent models): 15 mg/kg body weight, administered 12x daily Wound healing models: Local application at 110 g/wound site Reconstitution for Research GHK-Cu is typically supplied as a lyophilized powder
